ARTICLE | Company News
Arisaph deal
March 6, 2006 8:00 AM UTC
Arisaph granted an undisclosed U.S. company a non-exclusive license to its patents covering dipeptidyl peptidase-4 (DPP-4) inhibitors to treat diabetes. Arisaph received an upfront payment and is eli...